Investor Presentation First Nine Months of 2022

117 Investor presentation First nine months of 2022 GLP-1 market share and market growth in EMEA 80% 60% 40% 20% GLP-1 market growth and Novo Nordisk market share 0% Aug 2019 DKK GLP-1 market size and growth billion 80% -39% 2 66% 4 60% 60% 17 45% 39% 40% 20% 58% EMEA 23 ~45% 60% 0% Aug 2022 Aug 2021 Aug Novo Nordisk Eli Lilly Others 2022 NN market share Market growth (right axis) -NN share of growth Novo Nordisk Competitors -NN growth (right axis) Source: IQVIA, Aug 2022, Value, MAT, EMEA: Europe, Middle East and Africa; NN: Novo Nordisk

View entire presentation